AI Billionaire Investor: Executives Risk Nothing While Billions Ride on Their Calls

By Nathan Brooks

Giorgos Tsetis, the founder who built the supplement company Nutrafol into a multi-billion-dollar business and now invests in frontier AI firms including Anthropic and xAI, says no senior AI executive today faces personal legal accountability for the risks their systems create — and he wants that to change.

In a Fortune commentary published October 17, 2026, Tsetis writes that today's AI leaders "can make decisions from which they personally stand to make billions while risking nothing personally if their mistakes expose us all to danger."

His framing is blunt: "That asymmetry is indefensible."

Tsetis speaks from experience most AI investors lack. For nearly a decade he ran a company whose products people swallowed — hair growth supplements. If those products caused harm, he was legally on the hook. "Not just morally – legally," he writes. "It kept me awake at night. And that was a good thing."

What does this change for practitioners?

For AI executives, the argument cuts at a core protection: the corporate shield. Tsetis notes that financial penalties for corporate misconduct often run to a fraction of a company's turnover and valuations — a line item, not a deterrent. "Responsibility that stops at the corporate entity isn't responsibility," he writes. "It's an expense."

The asymmetry he describes is precise. An AI executive who misstates revenue to investors can already be held personally liable. Decisions that could contribute to outcomes ranging from an individual suicide to large-scale cyberattacks and geopolitical destabilization carry no personal legal jeopardy at all.

He points to social media as precedent for where that gap leads — and argues AI's stakes run higher.

The voluntary regime isn't enough

Tsetis isn't claiming regulators are idle. He acknowledges the current landscape:

• US states are introducing their own AI laws.
• Congress is weighing legislation that would impose safety requirements on frontier AI companies.
• At the end of September, leaders of several of the biggest AI companies signed an accord at the White House committing to internal risk controls, independent audits and board-level oversight of safety.

Leading labs have also published safety frameworks. Tsetis calls all of this welcome. But both the frameworks and the accord are voluntary — and "when it comes to AI, voluntary isn't enough," he writes. "Nothing yet holds the people at the top personally legally accountable."

How personal exposure changes behavior

The most practical passage in the piece draws on his Nutrafol years. "A safety checklist tells you what to test; personal exposure makes you worry about what isn't on the list," Tsetis writes. In his telling, liability changes operational habits: leaders drive teams to identify and test risks early, problems reach the top instead of getting smoothed over on the way up, and executives become willing to slow down or say no "even when money or a competitive edge is on the table, because your name is attached to what happens next."

He also addresses the innovation objection directly. Some argue another layer of accountability would stifle AI development. His answer: personal liability was essential to building the consumer trust that made his own company succeed, and "it could do the same for AI leaders."

Where he draws the line

Tsetis is careful not to demand punishment for every failure. No one can guarantee an AI system is perfectly safe, just as he couldn't guarantee every supplement was flawless. His proposed trigger points are specific:

• Leaders who know their systems pose serious risks and ship or release them anyway.
• Executives who inadequately fund safety teams or ignore their warnings.
• Companies that hide problems from regulators and the public.

In those cases, he argues, consequences should land on the individuals behind the decisions — not just the corporate entity.

He leaves the mechanics open: whether liability is civil or criminal, where thresholds sit, which harms count, and who audits what are decisions for "legislators, lawyers, technologists and ethicists." His one firm design principle: a named senior executive should be personally responsible for meeting whatever obligations emerge.

Why he thinks AI is different

Tsetis distinguishes AI from every other regulated industry, including his own. A supplement reaches only the people who choose to buy it. AI is embedding itself in power grids, hospitals, classrooms and aviation — systems everyone depends on whether they opted in or not. "We are all 'customers' of AI's products," he writes. A single failure, he argues, could ripple across a city, a country or beyond. He also notes that AI's own builders have warned the technology may one day escape human control — "extraordinary risks call for extraordinary accountability."

Tsetis invests through Great Things™, a new investment model, and his family office. Beyond Anthropic and xAI, his portfolio includes the compute infrastructure company Positron AI and Lila, an AI-enabled science and health platform. He says he's putting capital behind these companies because he wants them to succeed — which is exactly why he's pressing the ecosystem he funds to adopt a standard long applied to makers of products that go into human bodies, and now, he argues, must apply to makers of products that could shape humanity's future.